Nonthyroidal illness: A risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis?

Journal of Internal Medicine

Volumn 274, Issue 6, 2013, Pages 584-593

  Meuwese, Christiaan L ^a,b   Carrero, Juan J ^b   Cabezas Rodríguez, Iván ^b,c   Heimburger, Olof ^b   Barany, Peter ^b   Lindholm, Bengt ^b   Qureshi, Abdul R ^b   Ripsweden, Jonaz ^b   Dekker, Friedo W ^a   Stenvinkel, Peter ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Arterial stiffness; Coronary artery calcium score; Peritoneal dialysis; Thyroid hormones; Vascular calcification

Indexed keywords

ALBUMIN; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LIOTHYRONINE; THYROID HORMONE; THYROXINE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; ASSOCIATION; CALCIFICATION; CARDIOVASCULAR MORTALITY; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CALCIUM SCORE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PULSE PRESSURE; PULSE RATE; RENOVASCULAR DISEASE; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; WAVEFORM;

ARTERIAL STIFFNESS; CORONARY ARTERY CALCIUM SCORE; PERITONEAL DIALYSIS; THYROID HORMONES; VASCULAR CALCIFICATION;

ADULT; AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; EUTHYROID SICK SYNDROMES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; VASCULAR CALCIFICATION; VASCULAR STIFFNESS;

EID: 84887409223     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12107     Document Type: Article

References (45)

1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(Suppl. 12): S16-23.
2. Enkiri SA, Taylor AM, Keeley EC, Lipson LC, Gimple LW, Ragosta M. Coronary angiography is a better predictor of mortality than noninvasive testing in patients evaluated for renal transplantation. Catheter Cardiovasc Interv 2010; 76: 795-801.
3. Matsuoka M, Iseki K, Tamashiro M et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004; 8: 54-8.
4. Fensterseifer DM, Karohl C, Schvartzman P, Costa CA, Veronese FJ. Coronary calcification and its association with mortality in haemodialysis patients. Nephrology (Carlton) 2009; 14: 164-70.
5. Schwarz U, Buzello M, Ritz E et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-23.
6. Bellasi A, Ferramosca E, Ratti C, Block G, Raggi P. Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients. J Nephrol 2012; 25: 211-8.
7. Coen G, De Paolis P, Ballanti P et al. Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23. J Nephrol 2011; 24: 313-21.
8. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 1996; 17: 45-63.
9. Tatar E, Kircelli F, Asci G et al. Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 2240-6.
10. Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in end-stage renal disease. Kidney Int 2006; 70: 523-8.
11. Meuwese CL, Dekker FW, Lindholm B et al. Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2012; 7: 131-8.
12. Carrero JJ, Qureshi AR, Axelsson J et al. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med 2007; 262: 690-701.
13. Enia G, Panuccio V, Cutrupi S et al. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2007; 22: 538-44.
14. Tatar E, Sezis DM, Kircelli F et al. The association between thyroid hormones and arterial stiffness in peritoneal dialysis patients. Int Urol Nephrol 2012; 44: 601-6.
15. Yilmaz MI, Sonmez A, Karaman M et al. Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am J Nephrol 2010; 33: 25-32.
16. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. Thyroid function, endothelium, and inflammation in hemodialyzed patients: possible relations? J Ren Nutr 2007; 17: 30-7.
17. Bommer C, Werle E, Walter-Sack I et al. D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patients. J Am Soc Nephrol 1998; 9: 90-6.
18. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003; 88: 2438-44.
19. Rodondi N, den Elzen WP, Bauer DC et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304: 1365-74.
20. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 2002; 17: 1085-92.
21. Detsky AS, McLaughlin JR, Baker JP et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11: 8-13.
22. Chen CH, Nevo E, Fetics B et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997; 95: 1827-36.
23. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993; 14: 160-7.
24. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-32.
25. Raggi P, Callister TQ, Cooil B et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000; 101: 850-5.
26. Section I. Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transplant 2002; 17(Suppl. 7): 7-15.
27. Rozing MP, Westendorp RG, Maier AB et al. Serum triiodothyronine levels and inflammatory cytokine production capacity. Age (Dordr) 2012; 34: 195-201.
28. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002; 359: 1686-9.
29. Heinze G, Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics 2001; 57: 114-9.
30. Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999; 74: 243-52.
31. Ammirati AL, Dalboni MA, Cendoroglo M, Draibe SA, Fernandes Canziani ME. Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis population. Nephron Clin Pract 2006; 104: c33-40.
32. Stompor T, Rajzer M, Pasowicz M et al. Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis. Int J Artif Organs 2006; 29: 736-44.
33. Barreto DV, Barreto FC, Carvalho AB et al. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int 2005; 67: 1576-82.
34. Coen G, Manni M, Agnoli A et al. Cardiac calcifications: fetuin-A and other risk factors in hemodialysis patients. ASAIO J 2006; 52: 150-6.
35. Haydar AA, Hujairi NM, Covic AA, Pereira D, Rubens M, Goldsmith DJ. Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 2004; 19: 2307-12.
36. Ojamaa K, Klemperer JD, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996; 6: 505-12.
37. Tognini S, Marchini F, Dardano A et al. Non-thyroidal illness syndrome and short-term survival in a hospitalised older population. Age Ageing 2010; 39: 46-50.
38. Stenvinkel P, Wang K, Qureshi AR et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005; 67: 2383-92.
39. Mizuno I, Takahashi Y, Okimura Y, Kaji H, Chihara K. Upregulation of the klotho gene expression by thyroid hormone and during adipose differentiation in 3T3-L1 adipocytes. Life Sci 2001; 68: 2917-23.
40. Sato Y, Nakamura R, Satoh M et al. Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification. Circ Res 2005; 97: 550-7.
41. Stenvinkel P, Larsson TE. Chronic Kidney Disease: a clinical model of premature aging. Am J Kidney Dis 2013; pii: S0272-6386(12)01592-2. doi:10.1053/j.ajkd.2012.11.051 [Epub ahead of print].
42. Komar NN, Gabrielsen TO. Arterial calcification in adult cretins. Am J Roentgenol Radium Ther Nucl Med 1967; 101: 202-3.
43. Wojcicka A, Bassett JH, Williams GR. Mechanisms of action of thyroid hormones in the skeleton. Biochim Biophys Acta 2013; 1830: 3979-86.
44. Hafeman DM, Schwartz S. Opening the Black Box: a motivation for the assessment of mediation. Int J Epidemiol 2009; 38: 838-45.
45. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-9.